Microglia, the immune cells of the brain, are highly plastic and possess multiple functional phenotypes. Differences in phenotype in different regions and different states of epileptic human brain have been little studied. Here we use transcriptomics, anatomy, imaging of living cells and ELISA measurements of cytokine release to examine microglia from patients with temporal lobe epilepsies. Two distinct microglial phenotypes were explored. First we asked how microglial phenotype differs between regions of high and low neuronal loss in the same brain. Second, we asked how microglial phenotype is changed by a recent seizure. In sclerotic areas with few neurons, microglia have an amoeboid rather than ramified shape, express activation markers and respond faster to purinergic stimuli. The repairing interleukin, IL-10, regulates the basal phenotype of microglia in the CA1 and CA3 regions with neuronal loss and gliosis. To understand changes in phenotype induced by a seizure, we estimated the delay from the last seizure until tissue collection from changes in reads for immediate early gene transcripts. Pseudotime ordering of these data was validated by comparison with results from kainate-treated mice. It revealed a local and transient phenotype in which microglia secrete the human interleukin CXCL8, IL-1B and other cytokines. This secretory response is mediated in part via the NRLP3 inflammasome.
Introduction
Inflammation is both a cause and consequence of epilepsy and immune signals in an epileptic brain have several origins. Some acquired epilepsies develop after brain infections (Popkirov et al., 2017) and auto-immune epilepsies result from antibodies generated against brain proteins (Irani et al., 2011) . Inflammatory molecules facilitate epileptic activities (Vezzani et al., 2013; Chiavegato et al., 2014) . Immune signals in an epileptic brain have several origins. Neuronal death induces a persistent immune response (Amor et al., 2014; Peruzzotti-Jametti et al., 2014) . Furthermore, a seizure triggers a distinct immune reaction with secretion of inflammatory mediators (Vezzani et al., 1999; Ravizza et al., 2008) .
Glial cells participate in both persistent reactions to neuronal damage and dynamic responses to high levels of neuronal firing or seizures. Of the two major glial cell types, the role of microglia, brain-resident immune cells, has been less well studied. Microglia are highly plastic cells which, in response to neuronal, immune and vascular signals among others, change phenotype to assume distinct functional roles. Among functions relevant to an epileptic brain, microglia secrete inflammatory molecules (Charolidi et al., 2015) , extend processes towards damaged cells (Davalos et al., 2005) , phagocytose debris (Koizumi et al., 2007) and also protect neurons from damage (Park et al., 2007) .
Work in human epileptic tissue, obtained after operations to remove a focus (Crespel et al., 2002; Ravizza et al., 2008; Leal et al., 2017) , has shown that microglia and astrocytes are activated and pro-inflammatory molecules are upregulated, as in rodents. However, a more detailed study on immune cells and inflammation in human epilepsy is compelling for several reasons. First, recent data suggest human and rodent microglia may differ (Boche et al., 2013; Galatro et al., 2017) . Second, there are few data comparing basal profiles of microglia in regions of neuronal loss and gliosis with those of microglia in other regions of an epileptic brain with lower neuronal loss. In tissue from patients with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS), neuronal loss and gliosis are usually most severe in the CA1 or hilar regions and less pronounced in the subiculum (Blü mcke et al., 2013) . Third, data on immune responses to a seizure derive largely from convulsant applications to rodent brain resulting in a status epilepticus type of activity, which may last for several hours (Vezzani et al., 1999; Ravizza et al., 2008; Avignone et al., 2015) compared to most human seizures. Indirect evidence for an immune response to a human seizure consists of higher levels of inflammatory markers in blood (Virta et al., 2002) and transcriptomic changes in immune molecules and cells in tissue from patients reporting high seizure frequencies (Boer et al., 2006; Pernhorst et al., 2013) . Data on the delay between the last seizure and tissue collection are critical to specify the role of microglia in the response to a seizure.
Here we examine human tissue from patients with an intractable epileptic syndrome: MTLE-HS. We first compare basal phenotype, including shape, molecular markers and live responses to purinergic stimulation, for microglia in regions of greater or lesser neuronal loss in tissue from patients with MTLE-HS. Transcriptomic data were derived from whole tissue of different regions, to minimize phenotypic changes due to cell isolation. It suggested the repairassociated interleukin, IL-10, was a critical regulator in the sclerotic CA1 and CA3 regions. The dynamic response to a seizure was first examined by comparing transcriptomic data from tissue of patients reporting high or low seizure frequencies. Since few transcripts differed, we used reads for immediate early genes from each sample to estimate the delay from the last seizure until surgery. Ordering these delays revealed a fast, innate response including upregulation of the human cytokine CXCL8 and IL-1B. The involvement of specific cytokines was verified anatomically and was supported by ELISA analysis of secretion after seizure-like activity induced in acute human slices.
Materials and methods

Epileptic patients
This study was performed on tissue obtained after operations on 25 patients (eight male, 17 female; 23-66 years) diagnosed with MTLE-HS. Focal epileptic tissue was removed with minimal cauterization. All patients gave a written, informed consent. Protocols were approved by the Comité de protection des personnes, Ile-de-France (C16-16, 20152482) . Supplementary Table 1 gives the gender and age of patients, the type of hippocampal sclerosis (Blü mcke et al., 2013) , estimates for seizure frequency and the delay between the last seizure and surgery and other clinical information.
Temporal lobe tissue from epileptic patients
Blocks of temporal lobe tissue including the CA1 and CA2/CA3 regions, dentate gyrus/hilus and subiculum were transported in the following solution: sucrose 248, NaHCO 3 26, KCl 1, CaCl 2 1, MgCl 2 10, glucose 10 (mM; 4-8 C, 95% O 2 /5% CO 2 ). Tissue from 13 patients, with information on seizure timing, was used for both transcriptome and anatomical analysis. For transcriptome analysis, the dentate gyrus/hilus, the CA2/3 and CA1 regions and subiculum ( Supplementary Fig. 1 ) were separated and stored at À80 C. For anatomy, 400-mm thick slices were cut with a vibratome (HM650V, Microm), fixed with 4% paraformaldehyde and stored at 4-8 C. Tissue from six patients was used exclusively for anatomy. Tissue from six further patients was used for acute imaging and electrophysiology. Before recordings, 300-400-mm thick slices were stored at 20-24 C in: NaCl 125, NaHCO 3 26, KCl 4, CaCl 2 2, MgCl 2 2, glucose 10 (mM, 32-36 C, 95% O 2 /5% CO 2 ).
Mouse model of epilepsy
Kainic acid (50 nl, 20 mM) or NaCl (50 nl, 0.9%) was stereotaxically injected into one hippocampus of mice anaesthetized with ketamine (80 mg/kg) and xylazine (12 mg/kg). Injections were made in the CA1 region (anterior-posterior, 1.8 mm; medial-lateral, 1.8 mm; dorsal-ventral, 1.8 mm from the bregma). Brains were removed and the CA1 region was microdissected (laser capture, PALM Microbeam, C Zeiss) from cryostat-cut (50 mm, CM1950, Leica) sections. RNA expression was measured for micro-dissected tissue at 6 h, 1, 2, 4, 6 or 12 days after kainic acid injection.
Immunostaining
Human tissue, cryoprotected in 30% sucrose, was kept at À80 C. Cryostat-cut sections (20 or 50 mm) were incubated in phosphate-buffered saline (PBS) with bovine serum albumin (BSA, 3%) and Triton TM X-100 (0.1-1%). They were immunostained by exposure to primary antibodies at 4 C overnight and then to secondary antibodies at 20-25 C, for 2-3 h. Primary antibodies recognizing the following molecules were . Secondary antibodies were donkey anti-goat (Life Technologies A488; 1/500) and donkey anti-mouse (Life Technologies A555; A647; 1/500). Heat-induced antigen retrieval (citrate buffer, 95 C, pH 6) was used for CD68, MHCII and CD163. Nuclei were stained with DAPI. FOSB and CXCL8 were detected with a fluorescein amplification Kit (Perkin-Elmer). Slices were incubated in 1% Triton TM X-100, in 3% H 2 O 2 for 30 min and TNB buffer for 30 min, before exposure to FOSB or CXCL8 antibody in TNB (48 h, 4 C). Slices were then exposed to donkey antimouse HRP (2 h) before streptavidin (30 min) and fluorescein (10 min) to reveal FOSB or CXCL8.
Diaminobenzidine was used as a chromogen in immunostaining for other antibodies. Three micrometre sections were cut from formalin-fixed, paraffin-embedded tissue and immunolabelling performed by an automated system (5Ventana benchmark XT, Roche) with haematoxylin-eosin counterstaining. Primary antibodies recognizing PTGS2 (COX2, 1/300, polyclonal rabbit, Cayman Chemical) and GFAP (Millipore AB5804, 1/500) were revealed with the streptavidin-peroxidase complex with diaminobenzidine as chromogen.
Image acquisition and cell counting
Microglia and neuron density was measured automatically from 50 mm tissue sections immunostained for IBA1 and NeuN ( Supplementary Fig. 1D ). Other immunostaining data were derived from stacks of 10-50 images at 0.5-1.0 mm z-interval made from 20 mm slices with an inverted Olympus IX81 microscope using an Optigrid II (Thales Optem, Qioptik) and a Retiga EXI camera (Qimaging). Pixel sizes were 0.16 mm/pixel for a Â40 and 0.32 mm/pixel for a Â20 objective. Images were 1392 Â 1040 pixels. Binarization was not used. Co-localization of CXCL8, PYCARD and IBA1 was detected with ImageJ macros. PTGS2 immunopositive cells were visualized with a scanner (Nanozoomer, Hamamatsu).
RNAseq
RNA quantity (Nanodrop 1000, Thermo-Fisher) and RNA integrity number (RIN, Agilent 6000 Nano kit, Agilent Bioanalyzer 2100) were measured after extraction (Nucleospin XS kit, mouse; Nucleospin, human; Machery-Nagel). For human samples, the mean RIN number was 6.5 AE 1.0 (n = 44) and for mouse samples 7.0 AE 0.5 (n = 36). Samples were excluded when RIN quantity or integrity values were low. Libraries were made and sequencing performed at the Ecole Normale Supérieure Genomic Platform. For human samples, messenger (polyA + ) RNAs were purified from $300 ng of total RNA with oligo (dT). Libraries were prepared with a strand-specific RNA kit (TruSeq Stranded mRNA kit, Illumina) and multiplexed on flowcell lanes. Read sequencing (50 bp) was performed on a HiSeq 1500 device (Illumina). For mouse, 10 ng of total RNA was amplified and converted to cDNA (SMART-Seq v4 Ultra Low Input RNA kit, Clontech). Libraries were made from $180 ng of amplified cDNA (Nextera XT DNA kit, Illumina) and multiplexed on flowcell lanes. Read sequencing (75 bp) was performed on a NextSeq 500 device (Illumina). The mean number of passing human filter reads was 59 AE 5 million (n = 44) and for mouse tissue it was 80 AE 8 million (n = 36).
Read filtering, mapping, alignment filtering, quantification, normalization and differential analysis, were done with the Eoulsan pipeline (Jourdren et al., 2012) . Before mapping, poly-N read tails were trimmed, and reads with 540 bases or mean quality of 530 removed with SAMtools, Java . Reads for human RNA were aligned against the hg19 annotated human genome (STAR, v2.4.0 k). Mouse RNA reads were aligned to the mm10 mouse genome (Ensembl 81). Overlapping regions between alignments and referenced exons, or genes, were counted with HTSeq-count (v0.5.3).
Sample counts were normalized and transcript expression analysed with DESeq2 (v1.8.1; Love et al., 2014) . This package uses a negative binomial model to control count variability and the Benjamini and Hochberg correction for multiple comparisons. Defaults were 50.05 for the adjusted P-value and 0.1 for the false discovery rate. We searched for differential transcript expression in several contexts: (i) basal profiles of regions with different degrees of neuronal death; (ii) profiles of tissue from patients reporting high or low seizure frequencies; (iii) dynamic profile of kainic acid-and NaCl-treated mice at different delays; and (iv) in comparisons of each single human tissue sample with all other samples (all regions, all patients) to examine possible region-specific effects of a seizure. Supplementary material, part 4 describes the procedure for this comparison.
Ontology, pathways and cell type specificity of RNA species Ingenuity pathway analysis (IPA, Qiagen) used differentially expressed transcripts in an experimental dataset to derive enriched cellular functions and to predict upstream regulators such as cytokines. Statistical significance (P-overlap) of predictions was determined by comparing the number of differentially expressed transcripts in an experimental dataset with the total number of transcripts linked to a function or regulator. Z-scores were derived from agreement between the direction of predicted changes (up or down) and those present in the dataset. Supplementary material, part 2 describes the construction and validation of a list of microglia-enriched transcripts (Kuhn et al., 2011) . Supplementary material, part 4 describes procedures for pseudo-time analysis and Supplementary Tables 3-6 list all differential transcripts together with enriched functions and predicted regulators.
Imaging microglia in tissue slices
Living microglia were labelled with tomato lectin conjugated to a fluorescent marker (Dy-light 594, Vector Labs; Schwendele et al., 2012) injected from glass micropipettes (50 mg/ml) to label cells at depths of 70-150 mm in 300-mm thick slices. Images were captured using a Zeiss Axio Z1 microscope with two-photon illumination (3i Intelligent Imaging) from a Ti-sapphire laser (Chameleon, Coherent). The lectin was excited at 800 nm and emission measured at 620 nm. Objectives were 20Â , NA 1.0 or 40Â NA 1.0. ADP (2 mM) was applied in the artificial CSF bath perfusing solution.
Microglial motility and mobility were monitored from z-stacks of 30-40 mm at 0.5-1 mm collected at interval $2 min and analysed with Slidebook software (3i Intelligent Imaging). Microglial shape was reconstructed and kinetic behaviours analysed from z-stacks. Changes in microglia form were analysed by subtracting pairs of sequential images, to resolve changes in somatic area, process extension or retraction and membrane ruffling. Sidebook tools 'freehand selection' and 'polygon selection' were used to measure somatic area and arborization area for single cells. A morphological index was defined as the arborization area divided by the soma area. Bleb area was defined from lines drawn around extruded membrane.
ELISA measurement of cytokine release
Cytokine release was measured with an ELISA kit (human multi-analyte ELISA, Qiagen) for IL-1A, IL-1B, IL-2, IL-4, IL-6, CXCL8 (IL-8), IL-10, IL-12, IL-17A, IFNG, TNFA and GM-CSF. We tested supernatant collected over 2 h from slices in an interface chamber at 32-35 C, equilibrated with 95% O 2 /5% CO 2 . Seizure-like activity was induced in temporal lobe slices in an interface recording chamber by exposure to a solution containing (in mM): NaCl 125, NaHCO 3 26, KCl 8-10, CaCl 2 2, MgCl 2 0.1, glucose 10, equilibrated with 95% O 2 / 5% CO 2 at 34-36 C. Epileptiform activity monitored with tungsten electrodes was amplified (3600, AM Systems) and digitized to a PC (Digidata 1200A, Molecular Devices).
Statistics
Variance is stated as standard error on the mean unless noted. Microglial shape parameters ( Fig. 1) were compared with the Spearman correlation test and significance tested with the Kruskal-Wallis test. Changes in microglial shape during live records ( Fig. 3) were assessed with unpaired t-tests and correlation linearity tested with the Pearson r coefficient. Analyses including histograms and heat-maps were made with GraphPad Prism. Unsupervised cluster analysis based on Euclidean distances using Ward's procedure was executed from the site http://biit.cs.ut.ee/clustvis/. Enrichment of pathways and functions was assessed with the hyper-geometric test (https://www.geneprof.org/GeneProf/tools/hypergeometric.jsp).
Data availability
RNASeq data are stored at the Gene Expression Omnibus [NCBI (https://www.ncbi.nlm.nih.gov/); human data, accession number: GSE94744; mouse data, GSE99577).
Supplementary material is available at Brain online on: human epileptic tissue: patients, tissue preparation, counting and characterizing cells; data analysis strategies including extraction and verification of microglia specific transcripts; transcriptomic data and analysis on regions of high or low neuronal loss and seizure frequency; and procedures to compare RNA expression in one sample versus many control samples.
Other aspects of data presented here will be shared on reasonable request.
Results
Basal microglial phenotypes Shape
The human epileptic temporal lobe (MLTE-HS) includes the sclerotic CA1 and CA3 zones, where many neurons have died, the dentate gyrus and the subiculum, where fewer neurons have been lost and seizures may be initiated (Huberfeld et al., 2011) . How does microglial phenotype vary in these regions? As a first element of their phenotype, we measured the shape of IBA1-immunopositive cells (n = 283, nine patients). Even for cells of the same region, shape varied considerably (Fig. 1A) . While both microglia and macrophages express IBA1, we found that IBA1 + cells of all shapes co-expressed P2RY12 (Supplementary Fig. 1A and B), which is specific to rodent and human microglia (Mildner et al., 2017) . Microglial shape was classified by a cluster analysis of indices to measure their somata and processes (Fig. 1B) .
Canonical cells of these clusters ranged from highly ramified cells (cluster B2) to amoeboid cells with few processes (cluster A1), typical of activated microglia (Beach et al., 1995; Kettenmann et al., 2011) . Clusters discriminated between different numbers of primary or secondary ramifications ( Supplementary Fig. 2 ). Microglia with shapes corresponding to each cluster were found in each region (Fig. 1C) . Microglia with multiple secondary ramifications were most frequently situated in the subiculum (70% of cells in clusters B1 and 2) or the dentate gyrus (50% of cells in clusters B1 and 2). Those with few ramifications were found most often in CA1 and CA3 (60-70% of cells in clusters A1 and 2).
We asked whether different microglial shapes were correlated with local neuronal (Fig. 1D ) or microglial density ( Fig. 1E ) in the CA2/CA3, CA1, subiculum and dentate gyrus/hilus regions. Mean neuronal density was consistently lower in the CA1 and CA3 regions (Fig. 1D) , except for tissue from one patient with a distinct, type 3, pattern of sclerosis [Blü mcke et al. (2013) defines three types of hippocampal sclerosis according to neuronal loss in the CA3 region and the hilus]. Mean microglial density did not differ greatly between regions (Fig. 1E ). Microglial and neuronal density were well correlated in CA1 and CA2/CA3 (Fig. 1F ) but poorly correlated in the dentate gyrus and subiculum (Fig. 1G ). In regions of low neuronal density, amoeboid cells (cluster A1) occurred more often, and ramified cells (cluster B1) less frequently (Fig. 1H ). Microglial density and shape were not influenced by age or seizure frequency (Supplementary Fig.  3A and B).
These data show a strong, but not absolute, segregation of microglia according to shape. Amoeboid microglia were most frequent in the sclerotic CA1 and CA3 regions accompanied by neuronal loss and astrocyte proliferation (Supplementary Fig. 3G and H). Microglial density in these regions is correlated with neuronal density. Microglia ) in CA1, CA3, dentate gyrus and subiculum (n = 13 patients). The type of hippocampal sclerosis was 1, blue; 2, green or 3, red. Bar is mean AE SEM. (F) Microglia and neuronal densities were well correlated in CA1 (r = 0.75 P = 0.006, n = 12 patients) and CA3 (r = 0.72, P = 0.001, n = 12 patients) but less well correlated (G) in dentate gyrus (r = 0.24, P = 0.4, n = 13 patients) and subiculum (r = 0.19, P = 0.5, n = 14 patients). Spearman correlation, two tailed P-value. (H) Amoeboid microglia of cluster A1 (blue) were associated with regions of low neuronal density (r = À0.49, P = 0.006, n = 44; Spearman correlation) and ramified cells (cluster B1) with regions of higher neuronal density (r = À0.35, P = 0.01, n = 44; Spearman correlation, two-tailed P).
of the dentate gyrus tend to an intermediate shape with few processes while subicular microglia usually possessed multiple processes. Neuronal and microglial density were poorly correlated in the dentate gyrus and subiculum.
Molecular markers
We next examined markers associated with different functional microglial phenotypes. Reactive microglia express proteins of the major histocompatibility complex type II (MHCII). Immunostaining against MHCII revealed punctate labelling in the soma and processes of some IBA1 + microglia ( Fig. 2A) . The form of MHCII + cells, typically with simple ramifications, was significantly associated with clusters A1 and A2 (75%), and rather than B1 (60%) or B2 (30%) (Fig. 2B ). These cells (Fig. 2C) were located more often in the CA1 (78%) and CA3 regions (82%) than in the dentate gyrus (68%) or subiculum (32%).
Markers of phagocytotic microglia include the glycoprotein CD68 and the immunoglobulin Fc receptor CD16/32a. CD68 + elements of diameter 2-5 mm were present in the processes of some moderately ramified microglia (Fig. 2D ). Co-localization of CD68 staining with that for the glycoprotein LAMP1, and the protease cathepsin D (Fig. 2G ) identified CD68 + elements as phagosomes or lysosomes. Immunopositivity for the Fc receptor CD32a, confirmed the phagocytic phenotype of some microglia (Fig. 2H) . Cells expressing CD68 were not exclusively amoeboid but typically possessed moderate ramifications (Fig. 2E) and were detected in all regions (Fig. 2F) .
Dynamic responses to purinergic agonists
As a third element of microglial phenotype, we asked whether purinergic stimuli had different effects on amoeboid and ramified cells. Purines are liberated during a seizure (Kumaria et al., 2008) . Processes of healthy rodent microglia extend in response to purinergic stimuli (Davalos et al., 2005) , but 'activated' microglia in an inflamed brain retract their processes (Gyoneva et al., 2014) . We labelled microglia in acute tissue slices from MTLE-HS patients with a fluorescent tomato lectin (Schwendele et al., 2012) to compare the motility of amoeboid and ramified microglia using two photon microscopy.
We examine effects of ADP on amoeboid cells of the CA1 region and ramified microglia from subiculum. Before purinergic stimulation, amoeboid cells were largely static, while processes of ramified microglia moved continuously. ADP (2 mM, 30 min) induced responses with distinct kinetics in amoeboid (n = 7, three patients) and ramified (n = 7, three patients) microglia (Fig. 3A and B) . In amoeboid microglia, any short processes were retracted and somatic area increased over 5-15 min (Fig. 3C) . Processes of ramified cells retracted partially over 9-15 min ( Fig. 3B and D, yellow arrow). Ruffling was detected as a continuous extrusion and retraction of membrane from amoeboid cells or from the soma and processes of ramified microglia ( Fig. 3A and B, blue) . The latency to ruffling was significantly longer in ramified than in amoeboid microglia (Fig. 3E) . It was well correlated with their morphological index, the perimeter area of the tips of all processes divided by somatic area (Fig. 3F) . Microglial process retraction in response to ADP contrasts to the extension induced in healthy rodent cells.
Upregulation of IL-10 signalling in regions of high neuronal loss
These data show that while microglia were heterogenous, those of sclerotic and less sclerotic regions tend to differ in shape, markers and response to purines. Are these differences correlated with a distinct transcriptomic profile? We used RNAseq to analyse whole tissue from different regions thus minimizing potential phenotype changes during purification (Réu et al., 2017) and retaining links to the regional microenvironment. Our analysis strategy is described in Supplementary material, part 2. Since whole tissue RNA transcripts cannot be attributed to a specific cell-type, we constructed a list of microglia-enriched transcripts using a procedure based on seeding with microglia-specific transcripts (Kuhn et al., 2011) . The identity of differentially regulated transcripts let us define enriched cellular processes and predict upstream regulators including cytokines and transcription factors. Immunostaining tissue from the same blocks used for transcriptomics let us examine cell-type specific expression of proteins corresponding to differentially expressed transcripts or regulators.
Since microglia of the dentate gyrus were intermediate in shape (Fig. 1C ) and marker expression (Fig. 2C) , we compared RNA-seq data from the sclerotic CA1 and CA2/CA3 regions with that from subiculum (n = 12 patients). Figure 4A shows a Venn diagram of differential expressed in the sclerotic CA1 and CA3 regions compared to subiculum [n = 4014; P adjusted 5 0.05; 149 with log fold-change (FC) 42]. Analysis of cellular functions suggests common transcripts are associated with 'activation', 'proliferation' and 'differentiation' (Fig. 4B) . Comparison with the celltype specific list showed that 169 of 4014 transcripts were linked to microglia (Fig. 4A and Supplementary material, part 2). Enriched functions derived from the identity of these transcripts (Fig. 4C) were 'activation', 'differentiation', 'migration' and 'inflammatory response'. 'Phagocytosis' was not enriched when data from the CA1 and CA2/CA3 regions was compared to that from subiculum conforming to the presence of CD68 + microglia in both zones (Fig. 2F) .
The 169 microglia-related transcripts was then used to predict cytokine regulators of differences between sclerotic and less sclerotic regions. This procedure suggested IL-10, an antiinflammatory cytokine (Saraiva and O'Garra, 2010) , was associated with transcripts upregulated in the CA1 and CA2/3 regions. Actions of IL-10 tend to oppose those of Interferon gamma, IFNG, a cytokine associated with the classical activated microglial phenotype. Figure 4D shows reciprocal actions of IL-10 and IFNG on transcripts upregulated in regions with few neurons. They included the cytokines CXCR4 and CCR5, involved in cellular migration, proliferation and also neuronal survival (Louboutin and Strayer, 2013; Nash and Meucci, 2014) . Figure 4E summarizes differential expression of transcripts coding for immune receptors (blue), transcription factors (green), and secreted molecules (purple) in the CA1 and CA2/3 regions compared to subiculum.
Transcriptional regulators predicted from differentially expressed transcripts suggest that IL-10 may also be coupled to vascular genesis in regions of neuronal death. They included EPAS1/HIF2A and KLF2, which control the transcripts VCAM1 and ANGPT2 linked to 'angiogenesis', 'control of vascular morphology' and 'endothelial cell migration'. This prediction is consistent with angiogenesis described in tissue from MTLE-HS patients (Rigau et al., 2007) . Immunostaining for CD68 (magenta) in microglia, counterstained for IBA1 (green) and DAPI (blue) of clusters A1/A2 and B1/B2. Insets below: CD68 + vesicles in microglia processes. Scale bars = 10 mm, 5 mm for inset. (E) Density of CD68 + microglia for cells of clusters A1, A2, B1 and B2 and for (F) cells of the CA1, CA3, dentate gyrus and subiculum. Fewer microglia of cluster B2 were CD68 + , but little difference between regions. Each point is a mean of 15 microglia (n = 10 or 11 patients). Bar shows mean AE SEM. No significant differences were evident between areas. (G) Immunostaining shows CD68 (blue), LAMP1 (green), and Cathepsin D (red) co-localization in the phago-lysosome of an IBA1 + microglia (white). Scale bar = 10 mm. (H) CD32a (purple) staining, with IBA1 (green) and DAPI (blue) counterstain confirms the phagocytic phenotype. Scale bar = 10 mm. Asterisks in B, C, E, F show significance (Mann-Whitney two-tailed test at **P 5 0.01 and at *P 5 0.05).
To verify these predictions, immunostaining was used to compare expression of IL-10 and its targets in regions of high or low neuronal loss. IL-10 was strongly expressed in IBA1 + , CD68 + cells of the CA1 region, but low in subiculum. Some IL-10 + cells in CA1, clustered near blood vessels, may correspond to infiltrating macrophages (Fig.  4F) . CD163, an upregulated target of IL-10, was also expressed in IBA1 + cells near blood vessels in CA1 but not in subiculum (Fig. 4 G) . IL-10 also induces SOCS3, which suppresses cytokine signalling (Carow and Rottenberg, 2014) . SOCS3 was detected in both ramified and amoeboid IBA1 + cells in CA1, but was largely absent in IBA1 + cells of subiculum (Fig. 4H) . These data suggest the phenotype of microglia in regions with few surviving neurons is linked to IL-10 and favours neuronal survival and angiogenesis.
Effects of seizures
We next asked how a seizure changes microglial phenotype. First we compared the transcriptomic profile of tissue from patients reporting a high or low seizure frequency. A threshold of seven seizures per month separated six patients with high and six with low frequencies (Supplementary Table 1 ). Few transcripts were differentially expressed. In a region-byregion comparison, 47 transcripts were up-and 44 downregulated (CA1, CA3, dentate gyrus and subiculum; P adjusted 5 0.05 and logFC 4 2). Four coding transcripts were common to more than one region. Relaxing the logFC threshold (P adjusted 5 0.05; Supplementary Fig. 7 ) revealed upregulation of transcripts associated with inflammation in tissue from patients reporting a high frequency. the CA1 region and (B) a ramified microglia of the subiculum induced by 2 mM ADP. Two-photon imaging of cells stained with a fluorescent tomato lectin. At left, a microglia imaged at t = 0 and towards the right 3D reconstructions from t = 0, 5, 12 and 30 min after ADP stimulus onset. Scale bar = 10 mm. Light blue in 3D images, differences between successive reconstructions, shows ruffling of amoeboid and ramified cells. Yellow arrows for ramified microglia point to process retraction between 0 and 5, and between 5 and 12 min. (C) Time course of changes in mean somatic area (circles), arborization area (diamonds) and bleb area (triangles) for amoeboid microglia (n = 7, three patients) and for (D) ramified microglia (n = 7, two patients). (E) A longer delay from ADP application to membrane ruffling for ramified than for amoeboid microglia (two-tailed t-test, t = À4 554, ÃÃÃ P 5 0.001, n = 14, five patients). It seemed paradoxical to find weak transcriptomic differences between tissue associated with high or low seizure frequencies (Pernhorst et al., 2013 ) when a strong immune response occurs after a seizure in animals (Lerner-Natoli et al, 2000) . Several explanations are possible. A human seizure may have lesser effects than those of prolonged convulsant application in rodents. Reported frequencies may be unreliable if some seizures are not perceived (Cook et al., 2013) . A seizure may have occurred just before tissue was obtained from a patient reporting a low frequency. We followed two strategies. First, we sought information on the delay between the last seizure and operation (Supplementary Table 1 ). Second, we examined RNA-seq data for evidence of a recent seizure. Supplementary material, part 4 describes how we searched for differentially expressed transcripts in comparisons of each region of each sample (n = 1) with all other samples (n = 43; P adjusted 5 0.05, logFC 4 AE 1.5).
This procedure resulted in 44 sets of differentially expressed transcripts. Next, we attempted to sort them into a pseudo-time order (Trapnell et al., 2014) of delay from a seizure. Reads for immediate early gene transcripts were used as a surrogate molecular clock to measure time elapsed since recent strong neuronal activity (Ryan et al., 2011; Lacar et al., 2016) . We used the mean of reads for 10 transcripts: ARC, EGR1, FOS, FOSB, FOSL1, IER2, JUN, JUNB, NR4A1 and NR4A3. To validate this approach, we examined changes in the same transcripts after kainic acid injection in the mouse, where delay after a seizure can be accurately measured. Figure 5A shows mean normalized reads from human tissue sorted to a pseudo-time order. Data for the same transcripts in the CA1 region of mouse hippocampus collected at 6 h to 12 days after kainate injection are shown in Fig. 5B .
Immediate early gene transcripts were highly upregulated in some, but not all, samples of one patient, strongly upregulated in some samples from three other patients and downregulated for all others. In pseudo-time 1 tissue, from the patient with the shortest predicted delay from a seizure to tissue collection, reads were high in subiculum, increased to a lesser extent in CA2/CA3 but not in CA1 or dentate gyrus samples ( Fig. 5C and Supplementary Fig. 9 ). In pseudo-time 2 tissue, reads were high in dentate gyrus and CA2/CA3, but not CA1 or subiculum samples. Immediate early gene reads were low in all regions at late pseudo-time points. For each patient, the region with the highest mean reads for the immediate early genes was identified as the seizure associated area (Fig. 5C and Supplementary Fig. 9 ).
Predictions of a recent local seizure in some samples were tested by immunostaining for PTGS2, the prostaglandin synthetic enzyme, upregulated after a seizure, and for FOSB, an immediate early gene. Neuronal immunostaining for PTGS2 was restricted to seizure associated areas of tissue from short pseudo-times (Fig. 5D) . FOSB staining was also detected in predicted seizure-associated regions at pseudo-time 1, but was absent from all areas at pseudo-time 4 (Fig. 5E) .
Pseudotime ordering let us examine the time course of microglial activation after a seizure [ Fig. 5F(i-iv) ]. Analysis of differentially expressed transcripts for each sample with all other samples (1 versus 43) showed the function 'epileptic activity' was enriched in some, but not all regions, of samples from pseudo-times 1-8 [ Fig. 5F (i) and Supplementary material, part 4]. Immediate early genes were upregulated, in the same regions at pseudo-times 1-4 [ Fig. 5F (ii)]. The kinetics of microglial activation [ Fig. 5F(iii) ], derived from enrichment of transcripts of the microglia-filtered list (Supplementary Table 2) , followed a similar pattern to that of immediate early genes. In seizure-related regions at pseudo-times 1-4, we detected an increase in microglia of amoeboid shapes with few processes (clusters A1 and 2) and an increase in their expression of MHC II (Supplementary Fig. 3 ). Figure 5F (iv) confronts transcriptomic evidence with data from patients. Of four patients with the shortest estimated pseudo-times, two reported a high, and two a low seizure frequency. Two of these patients reported a seizure in the 4 days before tissue collection (Supplementary Table 1) . For further analysis, data were separated into three groups: early pseudo-times (1-4), mid pseudotimes (5-9) and late pseudo-times (10-13).
Local microglial response to a seizure
This procedure allowed us to identify transcripts upregulated in seizure-related regions at short pseudo-times (log 2 -fold change 4 AE1.5, P adjusted 5 0.05; Supplementary material, part 4). They included cytokines (Fig. 6A) , . Highest value from any area [CA1, CA3, dentate gyrus (DG), subiculum (SUB)] is shown for each patient. Reads from all transcripts normalized to 1 over all samples. (B) Mean reads for the same immediate early genes in mouse CA1 region tissue at defined delays after kainic acid (KA) treatment. Transcript differences between kainic acid (n = 3) or NaCl (n = 3) injected animals at 6 h to 12 days after kainic acid injection. Red line indicated mean of 10 transcripts. (C) Variation in mean reads for 10 immediate early genes from CA1, CA3, dentate gyrus and subiculum region of patients ordered to pseudo-times 1, 2 and 11. The region (arrow) with the highest mean value of immediate early gene reads was defined as seizure-associated area for pseudo-times 1 and 2. transcription factors (Fig. 6B) and other elements of an immune response (Fig. 6C) while the great majority of transcripts were not changed (Fig. 6A-C, insets) . Highly upregulated cytokines at pseudo-times 1-4 included the human inflammatory cytokine CXCL8, as well as the pro-inflammatory IL-6, IL-1B, CCL3 and the regulatory cytokine OSM (Fig. 6A) . Upregulated transcription factors included REL, an element of the NFKB family, MAFF, KLF4, NFKBIZ, a negative control of NFKB pathways and NR4A2, which inhibits production of inflammatory mediators (Fig. 6B) . Other transcripts upregulated at short pseudo-times included PTGS2, a synthetic enzyme of prostaglandins, GADD45B, SERPINE1, BCL2A1, a pro-apoptotic target of NFKB, and NLRP3, a component of the inflammasome (Fig. 6C) . As for immediate early gene transcripts [ Fig. 5C and F(ii) ], upregulation of those coding for cytokines and transcription factors was local. It was restricted to one or two regions of the same tissue sample from pseudo-times 1-4 ( Supplementary Fig. 10 ).
These conclusions depend on transcriptomic data from few patients. To validate them, we compared the identity of upregulated cytokine transcripts with that of cytokines secreted from MTLE-HS tissue slices after the induction of seizure-like activity ( Fig. 6D and E) . Slices from patients with unknown seizure history were used (n = 6). Seizure-like activity was induced with a high-excitability solution (8-10 mM K, 0.1 mM Mg; 30-60 min). Cytokine secretion was measured by multiplex ELISA on supernatant collected 2 h after induced seizures, compared to control slices with no induced seizures. The most highly secreted cytokine was the interleukin CXCL8 (Fig. 6E ). Significant increases were also detected for IL-1A 4 IL-1B 4 IL-6 4 TNFA (n = 6). Figure 6F shows upregulation of transcripts coding for these cytokines in seizure-related areas at pseudo-time 1 (CXCL8 4 IL-1A 4 IL-1B 4 IL-6 4 TNFA). Comparing the rank order of changes in reads to ELISA data on secretion gave a P-value of 0.0003. The anti-inflammatory cytokine IL-10 was not secreted. These data suggest that secreted cytokines conform to those with increased mRNA levels after a seizure.
We pursued this point by immunostaining for CXCL8 protein in the same tissue as used for transcriptomic analysis. CXCL8 was detected in the soma and processes of most microglia at all pseudo-times (Fig. 6G, purple) including both ramified (clusters B1, 2) and amoeboid (clusters A1 and 2) IBA1 + cells. In seizure-associated regions at pseudo-times 1-4, CXCL8 + staining was detected both inside microglia (Fig. 6H , white arrows) and extracellularly (Fig. 6H, yellow arrows) . On average, 18 CXCL8 + elements of diameter 1-2 mm were detected near each microglia. These data point to a local and transient secretion of CXCL8.
The NLRP3 inflammasome in the microglial response to a seizure Our data suggest the inflammatory cytokine IL-1B is also secreted after a seizure. Transcripts selectively upregulated in seizure associated areas at pseudo-times 1-4 (Fig. 7A and B) predict secretion may involve the NLRP3 inflammasome, a multi-molecular complex which processes some cytokines for release (Latz et al., 2013) . Predicted regulators linked to the inflammasome included NLRP3, PYCARD and CASP1 (Fig. 7A and B) . NLRP3 is a sensor molecule that may be activated by purines acting at the P2RX7 receptor (Franceschini et al., 2015; Jimenez-Pacheco et al., 2016) . Transcripts for NLRP3, CASP1, IL1B, CCL2 and CXCL8 were all upregulated at pseudo-times 1-4 (Fig. 7B) .
We therefore asked whether purinergic stimuli induced secretion of a similar spectrum of cytokines to those upregulated after seizure-like activity. Release was again measured by multiplex ELISA on supernatant collected over 2 h after exposure of acute tissue slices from MTLE-HS patients to ADP (2 mM, 30 min; n = 4). While cytokine secretion induced by ADP was less than that induced by seizure like activity, IL-1B, CXCL8, IL-6 and TNFA were detected at levels higher than control (n = 4; Fig. 7C ).
We attempted to confirm these predictions by immunostaining for NLRP3 and PYCARD in tissue from the blocks used for transcriptomic analysis. At pseudo-times 1-4, discrete aggregates of NLRP3 (Fig. 7D , white arrow) were apparent in 20-25% of microglia, particularly amoeboid cells. Confirming the transient increase in NLRP3 message from RNA-seq data, NLRP3 immunopositivity was not observed at later pseudo-times ( Fig. 7E and F) . In contrast, PYCARD signals were detected in most IBA1 + microglia (95%) at all pseudo-times in accord with transcriptomic data (Fig. 7G) . PYCARD co-localized with NLRP3 in somatic regions of 20% of IBA1 + cells at pseudo-times 1-4 (Fig. 7H , blue arrow). However, PYCARD signals, detected in 60% of microglia at later pseudo-times, were diffusely distributed throughout cellular processes (Fig. 7H, blue arrow) . This intracellular redistribution of PYCARD (Bryan et al, 2009 ) is consistent with a transient perisomatic assembly (Fig. 7I ) of the NLRP3 inflammasome for cytokine secretion.
Discussion
These data define two distinct phenotypes for microglia of human, epileptic temporal lobe. Cells in regions of intense neuronal loss tend to an amoeboid shape in contrast to a ramified form for those in regions with more surviving neurons. The anti-inflammatory cytokine IL-10 is a key influence on the phenotype of microglia in sclerotic regions. The second phenotype occurs transiently after a seizure. The secretion of inflammatory molecules including the human interleukin CXCL8 and IL-1B by microglia in a local region is mediated in part by the NRLP3 inflammasome.
Experimental design
We note several aspects of our approach. First, we analysed whole tissue from different regions of epileptic brain rather than purified microglia. While sorting removes doubts on cell-specificity, whole-tissue analysis minimizes changes in phenotype (Bohlen et al, 2017; Réu et al., 2017) and cell loss (Galatro, et al., 2017) during separation. Transcripts enriched in microglia were extracted with an analysis based on seeding with cell-specific transcripts (Kuhn et al., 2011) .
Second, the kinetic response to a seizure was examined using a pseudotime sorting procedure. Reads for immediate early genes were used to estimate the time between the last seizure and tissue collection. Immediate early genes are transiently activated by strong neuronal activity, so this approach was possible in whole tissue. Predicted kinetics of the response to a seizure were verified in several ways. First, by comparison with changes in the same transcripts in mouse tissue at known delays after an induced seizure. Second, from local expression of the early gene FOSB and PTGS2, in tissue where a recent seizure was predicted. Finally, predictions on cytokine secretion were validated by comparing the identity of upregulated transcripts with ELISA data on release after seizure-like activity induced in vitro.
Distinct basal phenotypes of microglia in different regions
We found a distinct basal phenotype, unrelated to seizures, for microglia in the CA1/CA3 regions, where few neurons survive in the MTLE-HS syndrome. RNA-seq data from the sclerotic CA1 and CA3 regions was compared to the subiculum. Microglia of the dentate gyrus apparently possess an intermediate profile (Blü mcke et al, 2007) . CA1/ CA3 cells tended to an amoeboid, rather than a ramified shape, expressed the activation marker MHCII more strongly and responded to purinergic stimuli more quickly than those in regions with more surviving neurons. Microglial phenotype in the CA1/CA3 regions may be related to a lower neuronal density, rather than to recent neuronal death since triggering events, such as a febrile seizure, occurred in these patients on average 25 years before we obtained the tissue (Supplementary Table 1 ). An inflammatory environment switches microglial expression of purinergic receptor subtypes to those promoting retraction rather than extension of cell processes in response to injury (Orr et al., 2009; Gyoneva et al, 2014) . Furthermore, purinergic stimuli induce changes in the membrane localization of P2RY12 receptors (Dissing-Olesen et al, 2014) . Our data showed ( Supplementary Fig. 6 ) enhanced numbers of transcripts for the receptors P2RX1, P2RY1, P2RY2 and P2RY13 in sclerotic areas and lower numbers of reads for P2Y14 and the adenosine receptor ADORA2B. Reads for the endonuclease ENTPD2 were higher and those for ENTPD3 lower in sclerotic regions. P2RY1 is associated with microglial migration (De Simone et al, 2010) .
The cytokine, IL-10, associated with repair processes (Park et al., 2007) , was identified, from the identity of differentially expressed transcripts, as a key regulator of microglial phenotype in the sclerotic CA1/CA3 regions of MTLE-HS tissue. Our data showed IL-10 is more strongly expressed in the CA1/3 region than in subiculum (Fig. 4F) . Transcriptomic data suggested it is not upregulated and ELISA data suggest it is not secreted after a seizure. Targets of IL-10 include SOCS3 and CD163 which promotes tissue regeneration (Akahori et al., 2015) . Our data also predict upregulation of growth factors, including CSF1 and TGFB1 and transcriptional regulators, EPAS1/HIF2A and KLF2, which control epithelial cell development and vascular remodelling (Favier et al., 2001; Novodvorsky and Chico, 2014) . Vascular remodelling may be epileptogenic if integrity of the blood-brain barrier is weakened (van Vliet et al., 2014) . However, IL-10 acts on tight junction proteins to reinforce the barrier (Lin et al., 2018) . The functional consequences of such compensation via the upregulation of molecules with regenerative actions, potentially opposed to pro-inflammatory actions, in regions of neuronal loss remain to be clarified. Comparing the vasculature in the glial scar of the CA1/CA3 regions and in the subiculum would be a first step to define regions of potential regenerative angiogenesis.
The origin of IL-10 remains to be defined. Immunostaining showed it was localized in IBA1 + cells, some of them closely apposed to blood vessels in the CA1 region. Staining with specific markers for infiltrating extracerebral immune cells would help determine if these cells differ from the IBA1 + and P2RY12 + microglia (Mildner et al., 2017) , Comparison of the numbers of brain resident microglia with infiltrating T-and B-lymphocytes in MTLE-HS tissue (Ravizza et al., 2008) suggests extracerebral cells have only minor effects on transcriptomic analyses.
A transient secretory phenotype after seizure activity Pseudotime sorting of RNA-seq data showed a seizure initiates a transient, secretory response. Immunostaining for Figure 6 Continued **P 5 0.01, or at *P 5 0.05 (n = 4-6 patients, Mann-Whitney, two-tailed P-value). (F) Fold enrichment of reads for the same cytokines in the seizure-associated area (defined from immediate early genes) at pseudo-time 1 compared to pseudo-times 5-13 (all areas, all patients). (G) Changes in the proportion of CXCL8 immunopositive microglia (purple), numbers of extracellular CXCL8 + vesicles at 510 mm from IBA1 + microglia (green) for pseudo-times 1, 4 and 6. Differences significant at **P 5 0.01 (n = 25-30 cells per patient, Mann Whitney, two-tailed P-value). (H) CXCL8 (green) and IBA1 (white) immunostaining in tissue from pseudo-times 1 and 6. Purple indicates CXCL8 co-localization with IBA1 (white arrow). Green shows extracellular CXCL8 vesicles (yellow arrow). Insets show co-localization at higher resolution. CXCL8 + microglia increased from pseudo-time 1 to 6. Extracellular CXCL8 + vesicles were detected only at pseudo-times 1 to 4. Scale bar = 10 mm. associated tissue at pseudo-times (ptime) 1-4. Heatmap of Àlog (P-value) for inflammasome components in seizure-associated regions (red box) at pseudo-times 1, 3 and 10. (B) Pathway for P2RX7 receptor, inflammasome activation and cytokine secretion (from IPA). Upregulated transcripts from pseudo-times 1-4, red. (C) Cytokine secretion (multiplex-ELISA) from superfusate of temporal lobe slices exposed to 2 mM ADP (red) or control solution (blue). Differences significant at *P 5 0.05 (n = 4-6, Mann-Whitney, two-tailed P-value). (D) Immuno-staining for NLRP3 (green) and PYCARD (purple) inflammasome components in IBA1 + cells (blue) of tissue from pseudo-time 4 and (F) pseudo-time 10. NLRP3 and PYCARD co-localize in microglia at pseudo-time 4 but not pseudo-time 10. Scale bar = 10 mm. (E) Proportion of microglia expressing NLRP3 and PYCARD (green) or only PYCARD (purple) at pseudo-times 1, 4, 5, 10 and 12 (mean AE SEM for 20 microglia per patient in all areas). PYCARD was present at all pseudo-times, but co-localized with NLRP3 only at pseudo-times 1-4 when (G) reads for NLRP3 were elevated. (H) Immunostaining of PYCARD (red) and IBA1 (white) at pseudo-time 1 and (G) pseudo-time 12. Blue indicates IBA1 and PYCARD co-localization (blue arrow). (I) As perisomatic NLRP3 was reduced, PYCARD migrated to microglia ramifications. Data from 20 microglia at pseudo-times 1-12.
the seizure markers FOSB and PTGS2 confirmed that effects were local, restricted to one or two regions, in agreement with transcriptomic evidence on cytokine upregulation. It may well depend on astrocytes as well as microglia.
Anatomical, transcriptomic and ELISA data suggest that CXCL8 was the most strongly secreted cytokine. CXCL8 has no rodent homologue (https://www.ncbi.nlm.nih.gov/ homologene/47937) and is absent from the Ensembl mouse database (http://www.ensembl.org). It does not appear in reviews of inflammatory targets in epilepsy based on rodent work (Aronica et al., 2017) . However, CXCL8 plasma levels increase strongly after febrile seizures in children (Gallentine et al., 2017) and it is synthesized by human microglia in response to inflammatory stimuli (Ehrlich et al., 1998) . In the periphery, CXCL8 is chemotaxic for monocytes and neutrophils (Charo and Ransohoff, 2006) , but actions in the brain are poorly defined. After a seizure, we detected CXCL8 at extracellular sites near microglia, presumably in vesicles (Fig. 6H) . While the identity of most human and mouse transcripts upregulated after a seizure was congruent, our data (Supplementary material, part 4) suggests five further human transcripts with no mouse homologue were upregulated.
Transcripts for the interleukin IL-1B were also strongly increased at short pseudotimes. Transcriptomic and anatomical evidence suggests the NLRP3 inflammasome, a macromolecular complex activated by purinergic stimulation (Di Virgilio et al., 2017) was a key element in IL-1B release. The identity of cytokines upregulated in transcriptomic data concurred with ELISA data on secretion after seizure-like activity but the profile of release induced by purinergic stimulation was not identical. Cytokine secretion probably does not depend uniquely on purinergic actions on the inflammasome (Lacy and Stow, 2011; Charolidi et al., 2015) .
Attention to cytokine secretion after a seizure might improve the management of epileptic patients. Of cytokines identified in this work, IL-1B, IL-6 and TNFA have proconvulsant actions on GABA and glutamatergic signalling (Stellwagen and Malenka, 2006; Kawasaki et al., 2008) and induce excitotoxic neuronal death (Ye et al., 2013) . There are less data on potential epileptogenic effects of CXCL8, but anakinra, an IL-1 receptor antagonist may be a useful therapeutic option as a CXCL8 antagonist (Kenney-Jung et al., 2016) . Therapeutic measures against cytokine-related targets could also protect against behavioural disorders linked to seizures. Elevated levels of inflammatory cytokines may degrade human mood, motivation and cognition (Dantzer et al., 2008) and induce depression (Mazarati et al., 2017) .
